SVETLANA MASTITSKAYA
SVETLANA MASTITSKAYA
About
Publications
Projects
Grants & Awards
Talks
Contact
Light
Dark
Automatic
cardiovascular diseases
Modulation of cardiac ventricular excitability by GLP-1 (glucagon-like peptide-1)
BACKGROUND. Glucagon-like peptide-1 receptor (GLP-1R) agonists improve cardiovascular outcomes in patients with type 2 diabetes mellitus. However, systemic actions of these agents cause sympathetic activation, which is generally considered to be …
Cite
×